skip to content

[Ad hoc announcement pursuant to Art. 53 LR] Roche exceeds guidance and achieves sales growth of 1% (CER) for 2023 despite sharp COVID-19 sales decline

Media

Media releases
view all

stay updated

get the latest news and updates to your inbox.